NASDAQ:BDSX

Biodesix Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy BDSX

*Your capital is at risk

$16.10

+0.660 (+4.27%)

At Close: Jun 03, 2026

Biodesix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.08. In total, the insiders bought 4.33M and sold 11.3K BDSX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.08
● Buy	4.33M shares
● Sell	11.3K shares
80% Buy Activity Weak Positive Correlation
Sell Signal Low Confidence Feb 23, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.08. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 15, 2026 Buy	Common Stock M-Exempt	O'kane Kieran Chief Commercial Officer	Officer	805 Value: $7K
Jan 15, 2026 Buy	Restricted Stock Units M-Exempt	Pestano Gary Anthony Chief Development Officer	Officer	805 Value: $7K
Jan 15, 2026 Buy	Common Stock M-Exempt	Vazquez Chris Chief Accounting Officer	Officer	219 Value: $2K
Jan 15, 2026 Buy	Restricted Stock Units M-Exempt	Vazquez Chris Chief Accounting Officer	Officer	219 Value: $2K
Jan 15, 2026 Buy	Common Stock M-Exempt	Pestano Gary Anthony Chief Development Officer	Officer	805 Value: $7K
Jan 05, 2026 Buy	Restricted Stock Units M-Exempt	Patience John Chairman	CEO / President	1 143 Value: $7K
Jan 05, 2026 Buy	Common Stock M-Exempt	Patience John Chairman	CEO / President	1 143 Value: $7K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Kennedy Lawrence T. Jr	Director	5 443 Value: $35.2K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Kennedy Lawrence T. Jr	Director	6 354 Value: $41.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Franchi Jean M. Director	Director	6 354 Value: $41.0K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Franchi Jean M. Director	Director	8 164 Value: $52.7K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Strobeck Matthew Director	Director	6 804 Value: $44.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Strobeck Matthew Director	Director	6 354 Value: $41.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Patience John Chairman	CEO / President	6 354 Value: $41.0K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Patience John Chairman	CEO / President	5 443 Value: $35.2K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Massarany Hany Director	Director	7 484 Value: $48.3K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Massarany Hany Director	Director	6 354 Value: $41.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Kayyem Jon Faiz Director	Director	6 354 Value: $41.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Hutton Scott President & CEO	CEO / President	97 000 Value: $626.6K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	29 000 Value: $187.3K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Vazquez Chris Chief Accounting Officer	Officer	12 000 Value: $77.5K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Kayyem Jon Faiz Director	Director	5 443 Value: $35.2K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	Pestano Gary Anthony Chief Development Officer	Officer	26 000 Value: $168.0K
Jan 02, 2026 Buy	Stock Options (Right to Buy) A-Award	O'kane Kieran Chief Commercial Officer	Officer	27 000 Value: $174.4K
Nov 10, 2025 Buy	Restricted Stock Units M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	158 Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIODESIX INC

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. ...

Read Full Profile Here